Robins Global News & Noticias 
RSS
Globe NewsWire News Distribution Service
RobinsPost partnered with Globe Newswire when it used to be owend by NASDAQ, to bring you the latest industry information from top companies. This partnership brought valuable information to help consumers receive the best product and news data on the web. The partnership was formed on September 14th, 2015.
NASDAQ YouTube Channel
Press Release: Glink Apps International Acquires Vietnam-based Company to Start M&A and IPO Plans
- Details
- Category: Globe NewsWire News Distribution Service
- Created: 24 January 2020
- Last Updated: 24 January 2020
- Published: 24 January 2020
- Written by Globe NewsWire Press Releases
New York, Jan. 24, 2020 (GLOBE NEWSWIRE) -- Glink Apps International, a Wyoming corporation, today announced that the Company has signed a Business Combination and Investment Agreement to acquire Glink Apps Vietnam Joint Stock Company to start its M&A plan and prepare to take the Company public on the U.S. Stock Market.
According to the Business Combination Agreement, the Company will acquire 100% of Vietnam-based Glink Apps Vietnam JSC in exchange for fifty million shares of common stock of Glink Apps International to be issued from the authorized and unissued stock capital of the Company. In addition, Glink Apps International will also invest in Glink Apps Vietnam to grow its business in the Southeast Asian markets.
The Company has retained PHI Capital Holdings, a wholly-owned subsidiary of PHI Group, Inc. (www.phiglobal.com) (OTC Markets: PHIL), to assist in its IPO and Mergers and Acquisitions plans. PHI Capital Holdings will be responsible for helping Glink Apps International throughout the entire process to become as a fully-reporting public company with the U.S. Securities and Exchange Commission and will also assist the Company to list on the NASDAQ Stock Market later on.
PHI Capital Holdings will also introduce investment banking firms, institutional and private investors and coordinate with these entities to provide capital for the Company to implement its business plan, as well as introduce investor relations agencies and other product and service providers to the Company as may be required during its normal course of business.
David Chinh Truong, Chairman and CEO of Glink Apps International stated: “We are pleased to start our M&A plan by signing the agreement to acquire Glink Apps Vietnam JSC as a wholly owned subsidiary of the Company. We intend to use Glink Apps Vietnam JSC as a platform to grow our business in the Southeast Asian markets and prepare to take the Company public on the U.S. Stock Market in the very near future.”
About Glink Apps International
Glink Apps International (formerly Glink Apps JSC), a Wyoming company, creates, sells, and distributes high quality art paintings. We provide a system to connect customers with service providers who deliver specific services. Our products and services include coffee shops which will feature art and coffee products in one place as well as Apps that provide services for entertainment, organizing music concerts, modeling events, online dating, entertainment competitions, songwriting, artwork, actors and actresses, plumbing, dentists, handyman services, employment, mechanics, painters, construction workers, etc. Website: https://Glinkart.com
About Glink Apps Vietnam JSC
Glink Apps Vietnam JSC’s current business activities include displaying and selling of artistic works, launching and franchising the Glink Coffee chain, organizing public events and granting international awards in connection with artistic works and music productions. In addition, Glink Apps Vietnam JSC is also engaged in real estate development and investment. The Company currently owns exclusive rights of many artistic and aesthetic talents.
Safe Harbor Act and Forward-looking Statements
This news release contains “forward-looking statements” pursuant to the “safe-harbor” provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may,” “future,” “plan” or “planned,” “will” or “should,” “expected,” “anticipates,” “draft,” “eventually” or “projected,” which are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements as a result of various factors.
Contact:
Glink Apps International
Ms :Pandora A.N. Le
Address: 2114 Senter Road #19, San Jose, CA 95112
Tel:+1-408-609-7218
Email:This email address is being protected from spambots. You need JavaScript enabled to view it.
https://glinkart.com,https://glinkglobal.com
Press Release: Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Correvio Pharma Corporation
- Details
- Category: Globe NewsWire News Distribution Service
- Created: 24 January 2020
- Last Updated: 24 January 2020
- Published: 24 January 2020
- Written by Globe NewsWire Press Releases
LOS ANGELES, Jan. 24, 2020 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 10, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of Correvio Pharma Corporation (“Correvio” or the “Company”) (NASDAQ: CORV) investors who purchased securities between October 23, 2018 and December 5, 2019, inclusive (the “Class Period”).
If you are a shareholder who suffered a loss, click here to participate.
If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Charles Linehan, Esquire, at 310-201-9150, Toll-Free at 888-773-9224, or by email to This email address is being protected from spambots. You need JavaScript enabled to view it., or visit our website at www.glancylaw.com.
On December 6, 2019, U.S. Food and Drug Administration (“FDA”) staffers who reviewed the Company’s resubmitted New Drug Application (“NDA”) for Brinavess found that the drug’s benefits did not offset its risks because Brinavess was associated with “serious liabilities” including irregular heartbeat, low blood pressure, and death.
On this news, Correvio’s share price fell $0.86 per share, or nearly 40%, to close at $1.30 per share on December 6, 2019, thereby injuring investors.
Then, on December 10, 2019, the FDA’s Cardiovascular and Renal Drugs Advisory Committee (“RDAC”) voted 11-2 against the resubmitted NDA, noting that the benefit-risk profile for Brinavess was inadequate to support approval.
On this news, Correvio’s share price further fell $0.94 per share, or more than 67%, to close at $0.46 per share on December 11, 2019, thereby injuring investors further.
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that the data supporting the Resubmitted New Drug Application ("NDA") for Brinavess did not minimize the significant health and safety issues observed in connection with the drug's original NDA; (2) that the foregoing substantially diminished the likelihood that the U.S. Food and Drug Administration would approve the Resubmitted NDA; and (3) that, as a result of the foregoing, the Company's financial statements were materially false and misleading at all relevant times.
Follow us for updates on Twitter: twitter.com/GPM_LLP.
If you purchased or otherwise acquired Correvio securities during the Class Period, you may move the Court no later than February 10, 2020 to request appointment as lead plaintiff in this putative class action lawsuit. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to This email address is being protected from spambots. You need JavaScript enabled to view it., or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contacts
Glancy Prongay & Murray LLP, Los Angeles
Charles Linehan, 310-201-9150 or 888-773-9224
This email address is being protected from spambots. You need JavaScript enabled to view it.
www.glancylaw.com
More Articles ...
- Press Release: DEADLINE ALERT - Prudential Financial, Inc. (PRU) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors With Losses Exceeding $100K of Class Action and Lead Plaintiff Deadline: January 27, 2020
- Press Release: Cowen Declares Quarterly Dividend On Its Series A Cumulative Perpetual Convertible Preferred Stock
- Press Release: Landmark Infrastructure Partners LP Announces Quarterly Distribution; Schedules Fourth Quarter 2019 Earnings Release and Conference Call
- Press Release: THE REALREAL DEADLINE ALERT: FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Deadline in Class Action Lawsuit Against The RealReal, Inc. - REAL
- Press Release: Sprague Resources LP Announces Cash Distribution for the Fourth Quarter of 2019 and Earnings Conference Call Schedule
- Press Release: Lasik Eye Surgery Devices Market to cross USD 1.9 Bn by 2025, Says Global Market Insights, Inc.
- Press Release: InterDigital Announces Participation in New 5G-CLARITY Project for Future Private Networks
- Press Release: Gold produced from the Julio Vein at Mexus’ Santa Elena mine
- Press Release: Cowen Opens London Stock Exchange, Reflecting Commitment to UK and European Capital Markets
- Press Release: Diet Demand Explains Why a Healthy Diet Alone Probably Won’t Lead to Quick Weight Loss
- Press Release: Rigrodsky & Long, P.A. Files Class Action Suit Against Tiffany & Co.
- Press Release: Applied Therapeutics, Inc. Announces Upsizing and Pricing of Public Offering of 2,741,489 Shares of Common Stock
- Press Release: Adaptive Announces Pricing of Public Offering of Common Stock
- Press Release: WBAI ALERT: ROSEN, A TOP RANKED LAW FIRM, Reminds 500.com Limited Investors of Important Deadline in Securities Class Action Commenced by the Firm – WBAI
- Press Release: Heritage Commerce Corp Increases Quarterly Cash Dividend 8% to $0.13 Per Share
- Press Release: SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Trulieve Cannabis Corporation - TCNNF
- Press Release: SmartFinancial Approves Regular Quarterly Dividend
- Press Release: Credit Acceptance Announces Timing of Fourth Quarter and Full Year 2019 Earnings Release and Webcast
- Press Release: Dime Community Bancshares Declares Quarterly Cash Dividend
- Press Release: Woodward Schedules Fiscal 2020 First Quarter Earnings Release and Conference Call
- Press Release: Pivot Bio and IN10T Team up to Rapidly Deliver Innovation that Displaces Fertilizer and Improves Farmer Outcomes
- Press Release: Gouverneur Bancorp Announces Fiscal 2020 First Quarter Results
- Press Release: Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Net 1 UEPS Technologies, Inc.
- Press Release: BESLER Achieves HFMA Peer Review Designation
- Press Release: Argus Research Initiates Equity Research Report Coverage on Envela Corp. (NYSE American: ELA)
